Mechanisms of Chronic Skin Ulceration Linking Lactate, Transforming Growth Factor-β, Vascular Endothelial Growth Factor, Collagen Remodeling, Collagen Stability, and Defective Angiogenesis  by Dalton, Stephen John et al.
Mechanisms of Chronic Skin Ulceration Linking
Lactate, Transforming Growth Factor-b, Vascular
Endothelial Growth Factor, Collagen Remodeling,
Collagen Stability, and Defective Angiogenesis
Stephen John Dalton1,2,3, Christine Vivienne Whiting2,3, Jennifer Ruth Bailey2, David Charles Mitchell1 and
John Francis Tarlton2
Up to one million people suffer from chronic skin ulcers in the US. Little is known of the mechanisms leading to
tissue breakdown, although inadequate circulation and ischemia are common elements in most dermal ulcers.
Collagen is the principal source of mechanical strength in most tissues, and its molecular and fibrillar stability is
dependent on adequate oxygen supply. In wound repair, localized ischemia leads to fibrogenic responses
culminating in elevated collagen synthesis and remodeling. This study examines factors influencing collagen
turnover and stabilization before ulceration in ‘‘at risk’’ patients. Severely ischemic but uninjured ischemic skin
(IS) was compared with patient- and site-matched non-ischemic skin. Biochemical mechanisms of tissue repair
were activated in IS, with increased lactate, transforming growth factor-b, vascular endothelial growth factor,
collagen synthesis and matrix metalloproteinases (MMPs)-1 and 2. The absence of MMP-9 and inflammatory
cells confirmed that this upregulation was inappropriate and not in response to injury. Molecular stability of
collagen was reduced in IS, and there was increased susceptibility to enzymic degradation. In conclusion,
chronic ischemia and long-term hypoxia result in elevated collagen remodeling in an oxygen-poor
environment. Unstable collagen molecules are synthesized together with upregulated MMPs, resulting in
collagen denaturation, defective angiogenesis, weaker skin, and predisposition to ulceration.
Journal of Investigative Dermatology (2007) 127, 958–968. doi:10.1038/sj.jid.5700651; published online 11 January 2007
INTRODUCTION
In the US up to one million people suffer from chronic leg
ulcers, with profound effects on the quality of life, and a cost
of $1.5–2 billion per annum (Harrington et al., 2000).
Ischemia secondary to peripheral vascular disease is a
significant cause of ulceration, with a large proportion of
leg ulcers of primarily venous or diabetic etiology also having
an ischemic component (Cornwall et al., 1986). Ulcers often
arise following minimal trauma, and lead to significant
morbidity, being the principal cause of lower limb amputa-
tion (London and Donnelly, 2000).
Studies investigating the pathology of chronic ulcers have
concentrated on processes taking place after ulcers have
formed (Tarlton et al., 1999), with none having investigated
processes that lead to the initial and progressive dermal
failure in ulceration. Thus, the mechanisms of structural
breakdown of the skin, and why ulcers form in the first place,
are largely unknown (Nanney, 2005).
Lactate is generated in tissue hypoxia, and though largely
a metabolite of skeletal muscle metabolism, skin is also a
significant lactate source (Johnson and Fusaro, 1972). It has
been measured in vivo by dermal microdialysis (Petersen,
1999); however, its direct measurement in skin biopsies and
as a measure of dermal ischemia has not been reported.
Lactate is an important mediator in the extracellular matrix.
Addition to cultured fibroblasts significantly increases both
their collagen (Klein et al., 2001) and transforming growth
factor-b (TGF-b) (Yalamanchi et al., 2004) synthesis. Lactate
also upregulates vascular endothelial growth factor (VEGF)
synthesis (Constant et al., 2000).
Collagen is the major component of the extracellular
matrix, providing most of its mechanical strength and much
of the organization of the scaffold on which cellular events
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occur. Type I collagen is the most abundant protein in skin. It
is synthesized as three separate a chains that assemble within
cells, such as fibroblasts, before secretion. Molecular oxygen
is required for the enzymatic hydroxylation of proline and
lysine, allowing stable triple helix formation before collagen
fibril assembly (Kivirikko and Pihlajaniemi, 1998), and for
lysyl oxidase-mediated crosslink formation during fibril
stabilization (Miles et al., 1995). Under-hydroxylation of the
collagen molecule would influence its stability, susceptibility
to enzymic degradation, mechanical strength of the skin, and
the formation of new blood vessels. A parallel may be seen in
scurvy (Akikusa et al., 2003), in which reduced collagen
hydroxylation owing to lack of ascorbate, a prolyl-4-
hydroxylase cofactor, results in loss of strength in the skin,
dysfunctional capillaries, and poor tissue repair.
TGF-b is integral in extracellular matrix remodeling
(Stampfer et al., 1993). It results in enhanced fibroblast
migration (Mogford et al., 2002) and proliferation (Strutz
et al., 2001), increases collagen (Bettinger et al., 1996) and
matrix metalloproteinase (MMP)-2 (Salo et al., 1991) synth-
esis and has an angiogenic effect on endothelial cells (Berse
et al., 1999; Vinals and Pouyssegur, 2001). TGF-b signaling is
mediated via two specific cell surface receptors, TRI and TRII.
Constitutively active TRII permits dimer formation with TRI,
its phosphorylation and signaling (Wrana et al., 1994), with
recruitment and phosphorylation of smad2 or smad3, which
then dimerise with smad4 to initiate gene transcription.
Smad6 and smad7, inhibit TGF-b signaling. Receptor binding
can be enhanced via interaction with TGF-b RIII (betaglycan)
or CD105 (endoglin) (Lopez-Casillas et al., 1993; Sanchez-
Elsner et al., 2001). TRI and TRII are expressed on most cells,
and TRIII and CD105 are highly expressed by endothelial
cells (Wong et al., 2000). CD105 is important in angiogenesis
and is used as a marker of neovascularization (Duff et al.,
2003).
VEGF is a key angiogenic factor promoting endothelial
cell proliferation, survival, and morphogenesis (Carmeliet,
2000). VEGF RII (KDR/Flk-1), expressed principally by
endothelial cells, promotes proliferation, and is upregulated
by VEGF (Shen et al., 1998). VEGF RI (Flt-1), expressed by
endothelial cells, fibroblasts, and leukocytes, is upregulated
in hypoxia via hypoxia inducible factor-1a (Gerber et al.,
1997), and acts as a negative regulator of VEGF signaling
probably by competing for ligand (Roberts et al., 2004).
In acute wounds, disruption of the microvasculature leads
to local hypoxia and elevated lactate. These factors stimulate
collagen synthesis (Hunt et al., 1978), with synergistic
hypoxia inducible factor-1a and TGF-b signaling leading to
elevated VEGF (Berse et al., 1999; Sanchez-Elsner et al.,
2001) and CD105 (Sanchez-Elsner et al., 2002) synthesis, and
increased angiogenesis promoting tissue repair. Upregulated
VEGF in human keratinocytes and dermal fibroblasts cultured
in hypoxic conditions (Detmar et al., 1997) has been shown
to stimulate fibroblast TGF-b (Falanga et al., 1991, 2002) and
collagen synthesis (Falanga et al., 2002).
Whether this mechanism also pertains secondary to
generalized ischemia is not known. We have previously
demonstrated that increased matrix remodeling occurs in
non-injured ischemic skin (IS), which may predispose to
dermal failure (Dalton et al., 2005). However, the mechan-
istic link between matrix changes and chronic ischemia, and
how this may lead to tissue breakdown, has not been
established.
We hypothesize that inappropriate metabolic processes
occurring in uninjured, chronically ischemic skin would
result in elevated extracellular matrix turnover and defective
matrix deposition, leading to mechanically weakened skin,
and predisposition to the formation of ulcers.
RESULTS
Lactate
Tissue lactate levels were significantly elevated in IS samples
(0.9470.09 mmol/l) (Figure 1a and b) when compared to the
non-ischemic skin (NI) patient matched pairs
(0.4770.07 mmol/l, Po0.001). No difference was found in
the lactate levels between NIS patient matched control and
varicose vein (VV) (0.2970.02 mmol/l) and total knee
replacement (TKR) (0.370.05 mmol/l) controls (Figure 1a,
P40.05 for both VV and TKR).
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Figure 1. Lactate in IS and control skin measured by colorimetric assay. (a)
Lactate levels in grouped ischemic samples compared to VV, TKR, and NI
controls expressed in mmol/l (Po0.001, unpaired t-test) and (b) lactate in
individual ischemic samples expressed as a percentage of the matched NI
values (Po0.001, Wilcoxon’s signed rank test).
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TGF-b1
The level of TGF-b1 within tissue extract was significantly
elevated in the IS (4.5870.86 ng/ml) compared to matched
paired NIS tissue (2.8470.67 ng/ml) (Figure 2a and b,
Po0.05); however, no significant correlation between lactate
and TGF-b1 was demonstrated.
TGF-b receptor expression
TGF-b RI and II were expressed by keratinocytes, vessel
endothelium and fibroblasts (Figure 3). TGF-b RI (Figures
3a, b and 4a) expression in the dermis (excluding large blood
vessels) was significantly increased in IS (Po0.01). TRI
expression was more prominent than TRII (Figure 3c and d)
and cells expressing TRII (Figure 4b) occupied a smaller area
of dermis (excluding large blood vessels) than TRI-expressing
cells (Figure 4a), with no difference between the NIS and IS
tissues; however, the distribution of cells expressing TRI and
TRII was similar in both IS and NIS skin. Colocalization
studies showed that TRI was predominantly expressed by
fibroblasts (5B5þ /TRIþ ) in the dermis with little expression
by CD45þ (CD45þ /TRIþ ) immune cells (data not shown).
Small vessels in the papillary dermis expressed both receptors
at lower level than large vessels, with large vessel endothe-
lium expressing both TRI and TRII at a level similar to that of
keratinocytes (data not shown). TRIII was strongly expressed
by keratinocytes and endothelium. There was no obvious
increase in TRIII expression intensity by either celltype in IS,
but there was an increase in vascularity in IS; therefore there
was an increase in area tissue expression of TRIII (Figure 3e
and f).
Smad signaling
TGF-b signals predominantly via activation of smad2 and
smad3, with subsequent negative regulation by smad7. The
area of dermis expressing phosphorylated smad 2/3 was
significantly increased (P¼ 0.031) in IS (Figures 3g, h, and
4c), whereas areas of dermis expressing inhibitory smad7
were significantly decreased in IS skin (Po0.014)
(Figures 3i, j and 4d). Large vessels (identified by morphology
and serial sections stained with VEGFRII) expressed smad
2/3 and smad7 at a high level, and were excluded from
analysis, but the expression of smad 2/3 and smad7 in the
remaining dermis was relatively low; therefore small blood
vessels, leukocytes, and fibroblasts were analyzed together.
Preliminary data indicated that a similar pattern of expression
was observed between an antibody against smad7 and that of
an antibody detecting both smad6 and smad7 (data not
shown). Immunoprecipitation of skin lysates for phosphory-
lated smad 2/3 revealed no difference between IS and NI skin
(data not shown), most likely due to the high level of
expression in keratinocytes and vessels in both groups (Figure
3h and j).
Collagen synthesis
Levels of type I collagen C propeptide (PICP), demonstrating
increased collagen synthesis, were significantly increased in
the IS (123.0717.04 ng/mg) compared to NIS-matched
paired samples (62.55713.64 ng/mg) (Figure 5a and b,
Po0.001), and also when compared to both the TKR
(49.2877.31 ng/mg) (Po0.01) and VV (46.6478.07 ng/mg)
(Po0.005) control tissues (Figure 5a). No significant
difference was demonstrated between NIS patient matched
control and VV or TKR controls (Figure 5a, P40.5).
A highly significant correlation was demonstrated between
collagen synthesis and lactate levels (Figure 5c, Po0.01, and
r¼ 0.42).
VEGF
VEGF levels were highly elevated in IS (0.9770.31 ng/mg)
compared to NIS-matched paired samples (0.1470.02 ng/
mg) (Figure 6a and b, Po0.01). A close correlation was seen
between lactate and VEGF levels (Figure 6c, Po0.001,
r¼ 0.55).
VEGF receptor expression
VEGR RI was expressed at low levels by endothelial cells,
keratinocytes, and non-endothelial cells in the dermis in NIS
(Figure 7a). A similar distribution and level of expression
were observed in IS; there were, however, areas where
elevated VEGF RI expression was associated with papillary
vessels in IS (Figure 7b). VEGF RII expression was confined to
vessel endothelium in the dermis of both NIS and IS samples
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Figure 2. Level of TGFb in IS and controls measured by ELISA. (a) Individual
samples (Po0.05, Wilcoxon’s signed rank test) and (b) ischemic samples
expressed as a percent of NI-matched pairs (Po0.05, Wilcoxon’s signed rank
test).
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(Figure 7c and d). Expression of VEGF RII was always
associated with vascular endothelial basement membrane
type IV collagen; however, both the area of endothelium
expressing VEGF RII and the intensity of expression were
elevated in IS (Figure 7d).
Angiogenesis
CD105 was strongly expressed by blood vessels and
keratinocytes in both NIS and IS dermis (Figure 7e and f).
Using CD105 as a marker for endothelium, which was clearly
distinguishable morphologically from convoluted epidermis,
it was observed that the area of CD105 in the dermis was
significantly increased in IS (0.0670.01 mm2/mm2) compared
to NIS (0.02870.005mm2/mm2) (Po0.01) (Figure 7g) and
expression appeared elevated in IS samples (Figure 7i). In 12/
16 IS samples, there were areas of vessel endothelium which
expressed CD105 without colocalization with type IV
collagen (Figure 7i), compared to only 1/16 NIS skin
samples (Figure 7h). These areas of single CD105-positive
endothelium were always close to the epidermis. An intact
epidermal basement membrane was observed in both tissue
groups.
Immune/inflammatory cells
CD45 is a pan immune cell marker labeling resident and
infiltrating cells including lymphocytes, macrophages, and
neutrophils. There was no significant difference in the area
of dermis positive for CD45 between IS (7.1%) and NIS
(5.6%, P¼ 0.37), demonstrating no inflammation in the IS
samples.
Molecular stability
The temperature of denaturation of the collagen triple helix,
Tmax, in IS was significantly lower than NI-matched pairs
(Figure 8a, P¼ 0.02).
Susceptibility to enzymic degradation
A significantly greater proportion of hydroxyproline was
released by pepsin digestion in the ischemic samples
compared with NI-matched pairs (P¼ 0.01, Figure 8b). Of
a
b
c
d
e
f
g h i j
Figure 3. Immunohistological localization of TGF-b receptor I, II, and III, and TGF-b signaling intermediates, in IS and control skin. (a, b) TRI, (c, d) TRII, and
(e, f) TRIII expression in (a, c, e) NI and (b, d, f) IS. (a, b) TRI expression was observed in keratinocytes, fibroblasts (small arrows), and vessel endothelium
(arrowheads) in the papillary dermis. (c, d) TRII expression was expressed similarly to TRI, but at a much lower level by fibroblasts. (e, f) Keratinocytes and
endothelium expressed TRIII. Phosphorylated (P) smad 2/3 expression in (g) NIS and (h) IS and smad7 expression in (i) NIS and (j) IS, arrows indicate small blood
vessels and arrowheads indicate large vessels. Bar¼ 20mm. Blue fibers in the dermis are due to autofluorescence.
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the 15 matched pairs, 12 demonstrated higher levels of
collagen degraded in the ischemic samples.
Mechanical strength of ischemic and NIS
Owing to the nature of the material, difficulties were
experienced fixing the skin in the Instron testing apparatus,
including breakage at the clamp margins, slippage, and
delamination. Despite these difficulties, IS was significantly
weaker (reduced stress at failure) than NI-matched pairs
(Figure 8c, Po0.05).
DISCUSSION
The pathophysiology of ulcer formation has received little
attention, as studies have largely concentrated on processes
taking place after ulcers have formed, such as impaired
healing (Tarlton et al., 1999). The factors which lead up to
structural and functional failure of the skin are not known.
Ischemia is a common element in ulcers of all etiologies, but
how such ischemia contributes to ulcer formation in
macroscopically normal skin is not known. We have
previously reported that increased matrix remodeling occurs
in IS (Dalton et al., 2005). Here we reveal mechanisms
linking tissue ischemia with the matrix changes that result in
weakened skin, increased but defective angiogenesis, and a
predisposition to ulcer formation.
Skin samples showed no physical evidence of injury, and
baseline expression of MMP-9 (Dalton et al., 2005),
depressed smad7 expression and no increase in immune
cells provided corroboration that the changes identified in IS
occurred in the absence of injury or trauma.
Increased type I collagen synthesis was seen in all samples
of uninjured IS, probably influenced by increased levels of
lactate and TGF-b. Elevated lactate levels resulting from
hypoxic metabolism have been demonstrated in porcine IS
flaps (Mortazavi-Haghighat et al., 2002), but this is the first
report in ischemic human tissue. TGF-b increases collagen
(Bettinger et al., 1996) and MMP-2 (Salo et al., 1991)
synthesis, and lactate upregulates both collagen (Klein et al.,
2001) and TGF-b (Yalamanchi et al., 2004) production in
vitro. Falanga et al. (2002) demonstrated that hypoxia-
stimulated collagen synthesis in cultured human fibroblasts,
and that this was TGF-b1 dependent (Falanga et al.,
2002). Combined elevated collagen and MMP-2 synthesis
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Figure 4. Image analysis of TGF-b receptor I, II, and TGF-b signaling
molecules in IS and control skin. Area of dermis (excluding large blood
vessels) expressing TRI and TRII. (a) TRI expression was significantly increased
in IS, (b) whereas there was no change in TRII expression in IS. (c) Area of
dermis expressing P-smad2/3 was increased in IS (large blood vessels
excluded), (d) whereas smad7 expression was decreased in IS (large blood
vessels excluded).
200
100
0
VV TKR NIS IS
PI
CP
 (n
g /m
g)
1,500
750
400
200
0
100
La
ct
at
e 
(m
mo
l/l)
200 300
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Patient number
PICP
%
 n
on
-is
ch
em
ic
0
10
20
a
b
c
Figure 5. Type I collagen synthesis in IS and control skin measured by ELISA.
(a) PICP levels in grouped ischemic samples compared to VV, TKR, and NI
controls expressed as ng/mg (Po0.001, unpaired t-test) and (b) PICP in
individual ischemic samples expressed as a percentage of the matched NI
values (Po0.001, Wilcoxon’s signed rank test). (c) Correlation between
lactate and PICP levels (Po0.01 and r¼ 0.42).
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demonstrated increased matrix turnover which is inappropri-
ate in uninjured skin (Dalton et al., 2005).
Fibroblasts, which synthesize skin collagen, apparently
expressed more TGF-bRI than TRII. Colocalization studies to
determine which cell types within the dermis express TGF-
bRI showed that TRIþ cells were principally fibroblasts
(5B5þ ) rather than CD45þ immune cells. The precise
balance of receptor expression may result in differential
effects, as RI mediates fibronectin synthesis, but growth
inhibition is more dependent on TRII (Geiser et al., 1992). TRI
levels were significantly increased in ischemic dermis;
therefore the increase in type I collagen synthesis in ischemic
tissue was probably due to a combined effect of elevated
TGF-b acting via increased dermal receptor expression by
fibroblasts.
VEGF was also elevated in IS, which, like TGF-b, is a key
factor promoting angiogenesis. TGF-b has been shown to
promote endothelial cell survival and morphogenesis in
4
3
2
1
0
NIS IS
VE
G
F 
(ng
 /m
g 
dr
y 
wt
)
2,600
2,400
2,200
2,000
1,800
1,000
800
600
400
200
0
1 2 3 4 5 6 7 8 9 10111215161718192021
Patient number
%
 n
on
-is
ch
em
ic
10
1
0.1
0.01
0.0 0.5 1.0 1.5
Lactate (mmol/l)
VE
G
F 
(ng
 /m
g)
a
b
c
Figure 6. VEGF expression in IS and control skin measured by ELISA. VEGF
levels in (a) grouped IS and control skin (Po0.001, Wilcoxon’s signed rank
test) and (b) individual ischemic samples expressed as a percentage of the
matched NIS (Po0.001 Wilcoxon’s signed rank test). (c) Correlation between
VEGF and lactate (Pearson correlation, P¼ 0.0003, r2¼ 0.3048).
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Figure 7. Immunohistological localization of CD105, VEGF receptors I and
II, and Type IV collagen in IS and control skin. (a, b) VEGF RI, (c, d) VEGF RII,
and (e–i) CD105 expression in (a, c, e, h) NI and (b, d, f, i) IS skin. (a, b) VEGF
RI was expressed by vessel endothelium (large arrowheads) and non-
endothelial cells (large arrows) in the dermis. (c, d) Endothelial VEGF RII
(FITC) colocalized with basement membrane type IV collagen (Texas Red,
overlapping expression with FITC is yellow, large arrowheads). (e, f) CD105
was expressed by vessel endothelium (arrow heads) and keratinocytes, and (g)
the area of dermal expression significantly increased in IS (Po0.01). CD105
(FITC) colocalized with type IV collagen (Texas Red) in (h) NIS and (i) IS (large
arrowheads), but in IS there were also areas where RII and type IV collagen
were not coexpressed (large arrows). Epidermal basement membrane (small
closed arrows, c, d, h, i). Bar¼20 mm. Blue fibers in the dermis are due to
autofluorescence.
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three-dimensional collagen gels (Vinals and Pouyssegur,
2001), to induce production of VEGF (Berse et al., 1999).
VEGF promotes endothelial cell growth and survival (Carme-
liet, 2000). Increased levels of VEGF protein in IS indicate
activation of the oxygen-sensing transcription factor, hypoxia
inducible factor-1a, which binds to a response element in the
VEGF gene promoter. Detmar et al. (1997) showed that VEGF
mRNA expression was dramatically upregulated in keratino-
cytes and fibroblasts from human skin explants in response to
hypoxia and Berse et al. (1999) showed that such conditions
doubled the rate of VEGF secretion stimulated by TGF-b1. We
have demonstrated a significant increase in VEGF in uninjured
but chronically ischemic skin, probably mediated via hypoxia
inducible factor-1a and an upregulation of TGF-b1.
VEGF regulates endothelial cell proliferation, survival, and
morphogenesis via VEGFRI and RII (Carmeliet, 2000).
Elevated levels of VEGF in IS probably led to the raised
endothelial VEGFRII expression and greater area of CD105þ
endothelium, a marker for angiogenesis used previously
(Vermeulen et al., 1996). We have demonstrated that CD105
is clearly expressed by endothelium in normal skin blood
vessels and expression increased in chronic ischemia.
Detmar et al. (1997) showed that both VEGFRI and RII
mRNA were expressed at very low levels in normal skin and
that hypoxia upregulated mRNA for both receptors in explant
culture. VEGFRI, which is upregulated by hypoxia via
hypoxia inducible factor-1a (Gerber et al., 1997), acts as a
negative regulator of VEGF signaling, allowing controlled
vascular morphogenesis (Kearney et al., 2004). It was
expressed at relatively low levels in both ischemic and non-
ischemic skin; however, there were patches of intense
expression in endothelium and surrounding cells in the
papillary dermis in some ischemic samples, possibly indicat-
ing areas of lowest oxygen tension. Blood vessels formed in
tumors, which are considered hypoxic, and may lack
basement membranes or pericytes, resulting in ineffective
function (Sivridis et al., 2003). Therefore, areas where
CD105þ endothelium occurred without concordant expres-
sion of type IV collagen provide some evidence for defective
angiogenesis in chronically ischemic skin.
We have previously shown that increased collagen
synthesis in IS does not result in increased net collagen
deposition (Dalton et al., 2005). Evidence here suggests that
this may be a result of instability in the collagen molecule
(Dalton et al., 2003). Proline hydroxylation in collagen is
essential for its molecular stability as hydroxyproline forms
H-bonded water bridges through the hydroxyl group and the
peptide chain (Kivirikko and Pihlajaniemi, 1998). In scurvy,
for example, unstable under-hydroxylated type IV collagen
deposition results in impaired angiogenesis (Mahmoodian
and Peterkofsky, 1999), owing to reduced prolyl-4-hydro-
xylase activity resulting from lack of ascorbate, an essential
cofactor for prolyl-4-hydroxylase. Impaired collagen hydro-
xylation may also occur in hypoxic conditions (Alper et al.,
1982), as oxygen is also an essential coreagent. This would
also result in unstable collagen, including types I, III, and IV,
leading to dysfunctional angiogenesis, increased susceptibil-
ity to denaturation and proteolytic degradation, and reduced
mechanical strength.
There was direct evidence that the inappropriate matrix
turnover combined with hypoxia in chronically ischemic,
uninjured skin led to a destabilized collagen triple helix and
weakened skin. Collagen stability was assessed using
differential scanning calorimetry. Tmax represents the thermal
stability of the triple helix, which is strongly influenced by the
presence of hydroxyproline residues, with one in seven
proline molecules hydroxylated in normal collagen. The
significant reduction in Tmax in IS demonstrates reduced
molecular stability of the collagen and implies reduced
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Figure 8. Properties of IS. (a) The thermal stability (temperature of
denaturation; Tmax) of the collagen molecule, measured by differential
scanning calorimetry, was significantly lower in IS compared with NI controls
(P¼0.02, Wilcoxon’s signed rank test). Results expressed as a percent of NI.
(b) Susceptibility of collagen to pepsin digestion, measured by hydroxyproline
release. IS is significantly more disposed to enzymic degradation than NIS
(P¼0.01, Wilcoxon’s signed rank test). (c) Mechanical strength (stress at
ultimate failure; Mpa) of IS was significantly lower than NI control skin
(Po0.05, Wilcoxon’s signed rank test).
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hydroxyproline content, which may be expected in condi-
tions of oxygen deficiency and inhibition of prolyl-4-
hydroxylase. Resistance to proteolytic attack is a character-
istic of stable triple helical collagen, and reduced stability of
the collagen molecule may also result in increased suscept-
ibility to proteolytic degradation, as demonstrated by
increased dissolution of collagen by pepsin in the ischemic
samples. Increased susceptibility to digestion by nonspecific
proteases is also important in the pathology of ulceration,
reducing strength and increasing the predisposition to dermal
breakdown. Despite the technical difficulties in determining
mechanical strength of skin, we were able to demonstrate
that IS is indeed weaker than matched paired NIS controls.
In this study, we have demonstrated increases in lactate,
TGF-b levels and signaling, VEGF, and angiogenesis, all
normally associated with tissue repair processes, yet here
manifest in uninjured, non-inflamed, but chronically is-
chemic skin. This results in increased collagen synthesis
and remodeling (Dalton et al., 2005). Simultaneous with this,
the newly deposited collagen is both unstable and more
susceptible to enzyme digestion (Dalton et al., 2003). As a
consequence of these two processes, the skin is weakened
and more susceptible to breakdown, and angiogenesis is
impaired, possibly exacerbating the ischemia at a local level.
We propose a novel mechanistic model for dermal break-
down in ulceration. Tissue exposure to chronic oxygen
deprivation in ischemia leads to secretion of inappropriate
levels of TGF-b and VEGF, resulting in increased collagen
synthesis and raised levels of degradative MMPs. The
collagen produced in a low-oxygen environment is unstable
as a result of oxygen deficiency in molecular and fibrillar
stabilization processes. This unstable collagen is weaker and
has increased susceptibility to proteolytic attack, in an
environment with increased expression of degradative MMPs.
These factors lead to a weakened dermis and a predisposition
to chronic ulceration, which may occur after relatively minor
trauma to the skin.
This study provides insights into mechanisms in skin
ulceration, and potential clinical targets, such as reducing
collagen turnover or optimizing tissue oxygen utilization by,
for instance, upregulating prolyl-4-hydroxylase. It is recog-
nized that the de-stabilization of collagen identified here may
be a factor in other degenerative diseases where rapid or
elevated matrix turnover occurs alongside hypoxia. This may
be important in diseases such as intervertebral disc degen-
eration, osteoarthritis, and tendonitis, as well as other
ischemic disorders.
MATERIALS AND METHODS
Unless otherwise stated, reagents were obtained from Sigma (Poole,
UK). Procedures involving human subjects were approved by all
appropriate local Ethical Review Panels, and comply with the World
Medical Association Declaration of Helsinki on Ethical Principles for
Medical Research.
Sample collection and preparation
Following written informed consent, 8-mm skin biopsies were
taken at operation from the lower limbs of 21 patients (10 female,
11 male, mean age 72; range, 62–84) undergoing below-knee
amputation for peripheral vascular disease, from both proximal (NIS)
and distal (IS) sites as described previously (Dalton et al., 2005).
Patients had documented peripheral vascular disease for at least a
year, with ankle brachial pressure ratios of less than 0.4 indicating
severe ischemia. Control skin taken at TKR (n¼ 7, mean age 71;
range, 57–81) and VV (n¼ 8, mean age 55; range 34–68) surgery
was used as proximal- and distal site-matched controls, respectively.
Assessment of patients, determination of ischemia, and sample
preparation were as described previously (Dalton et al.,
2005). Tissue was pulverized, freeze dried, and extracted for
24 hours in 20 ml of extract buffer (20 mM triethanolamine and
0.1% Brij) per mg dry weight, the mixture centrifuged, and
supernatant separated from the insoluble matrix pellet. Fat extraction
was performed on the pellet using 2:1 chloroform/methanol, in order
to establish the true dry mass of the skin, which was used in all
compositional calculations. Samples were stored at 801C until
required.
Tissue lactate
Samples were examined in matched pairs. Freeze dried tissue was
re-suspended at 2 mg/ml in phosphate-buffered saline (PBS). Samples
were mixed at 41C, centrifuged for 5 minutes at 13,000 g, and
supernatants were tested for lactate using colorimetric enzymatic
determination (Sigma) on a 96-well assay plate. Absorbance was
read at 540 nm. Concentrations of lactate were calculated against a
standard curve using Labsystems Genesis software (ThermoLife
Science Int, Basingstoke, UK).
TGF-b1
Total TGF-b1 levels were assessed by ELISA in acid-activated sample
extract (50 ml) in triplicate as described previously (Whiting et al.,
2001).
Immunohistology
Matched pairs of frozen sections were processed and analyzed for
TGF-bRI, TGF-bRII, TGF-bRIII, CD105, phosphorylated-smad2/3,
smad7, CD45, VEGFRI, VEGFRII, and type IV collagen using
peroxidase conjugates or multiple immunofluorescence. All anti-
bodies are listed in Table 1.
Eight-micron frozen sections from matched pairs were cut onto
the same slide, air-dried, fixed in acetone at 41C for 10 minutes
and then rehydrated in PBS for 10 minutes. Nonspecific binding
was blocked with sera þ / non-fat milk powder in PBS for 1 hour at
201C (Table 1), followed by an avidin/biotin block (Vector
Laboratories, Peterborough, UK). Owing to nonspecific binding of
rabbit IgG a stringent blocking procedure was used as follows.
Following 1% normal rabbit serum block (Table 1), sections were
incubated with 1:25 donkey anti-rabbit Fab (Stratech, West
Grove, PA). Primary antibodies, or equivalent immunoglobulin
controls, were added to sections at concentrations listed in Table 1
and incubated at 41C overnight. Sections were washed in PBS
and then biotinylated secondary antibodies (Stratech) were applied
for 1 hour at 201C. Staining was developed using either (1)
peroxidase-conjugated Streptavidin biotin complexes (Vector)
with diamino benzidene as substrate followed by a light
counter-stain with Mayers hematoxylin, dehydration and mounting
or (2) streptavidin-dichlorotriazinyl amino fluoriscein (DTAF)
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(Table 1). For double labeling, primary antibodies were applied
together overnight, followed by biotinylated anti-mouse and
finally donkey anti-goat-FITC plus streptavidin, Texas Red.
Images were viewed using a Leica DMRB microscope (Leica UK,
Milton Keynes, UK) and grabbed using a Colour Coolview
charge coupled device camera (Photonic Sciences, Robertsbridge,
E Sussex, UK) and Image-Pro Plus software (Media Cybernetics,
Baltimore, MD).
Peroxidase-stained sections were analyzed for the area of dermis
expressing CD105 using images grabbed with the  10 objective.
RGB profiles for positive expression was determined using levels at
least twice background intensity in each channel. Six fields were
grabbed per sample and the area of analysis defined to exclude
epidermis. Results are expressed as (mm2) CD105þ endothelium/
mm2 dermis. Samples were coded, processed in matched pairs, and
analyzed blind.
Collagen synthesis
Type I collagen C propeptide (PICP) was quantitated by ELISA
(Prolagen CTM, Quidel, Oxon, UK). Tissue extracts were diluted 1:12
in assay buffer and absorbance read at 405 nm. PICP concentrations
were calculated against a standard curve using Labsystems Genesis
software (Tarlton et al., 1999).
VEGF
VEGF was measured by ELISA (R&D, Oxford, UK). Tissue extracts
were diluted 1:3 in PBS and absorbance read at 450 nm.
Concentrations of sample VEGF were calculated against a standard
curve using Labsystems Genesis software.
Molecular stability
The molecular stability of the collagen triple helix determines the
energy required to bring about denaturation. The heat capacity is a
measure of the energy of denaturation, and may be quantified by
differential scanning calorimetry (Miles et al., 1995). Unprocessed
tissue (5 mg) was thawed at room temperature, re-hydrated for 1 hour
in PBS to ensure comparable hydration and pH, and sealed into a
pre-weighed aluminum pan (Perkin Elmer, Beaconsfield, UK). A
baseline reading was obtained by loading two empty pans onto a
Perkin Elmer differential scanning calorimetry-2 calorimeter before
loading samples. Samples were heated from 10 to 1101C at a rate of
101C per minute using nitrogen as the flushing gas and a thermogram
was generated. The pans were then punctured to release the seal,
freeze dried overnight, reweighed to determine the sample dry
weight and then hydrolyzed in 5 ml 6 M HCL. Hydrolysates were
reconstituted in water and the total collagen content calculated
using hydroyproline analysis as described previously (Dalton et al.,
2005). From the thermogram, Tmax is recorded as the temperature at
maximum heat capacity.
Susceptibility to enzymic degradation
Resistance to proteolytic attack is a characteristic of triple helical
collagen. Increased susceptibility to nonspecific proteolysis is
important in the ulcer pathology, as well as a measure of molecular
Table 1. Primary and secondary antibodies
Antibody Code/clone Host Serum block Concentration (lg/ml) Source
Target
TGF-b RI sc-398 Rabbit NDS 10%, NRS 1% 4 SC
TGF-b RII sc-400 Rabbit NDS 10%, NRS 1% 1 SC
TGF-b RIII sc-6199 Rabbit NDS 10%, NRS 1% 1 SC
Smad7 sc9183 Goat NDS 10% 4 SC
P-Smad2/3 3101 Rabbit NDS 10%
NRS 1% 2 CS
CD45 MCAP87 Mouse NRS 10% 5 SE
Collagen IV AD4 Mouse NRS 10% 1 GP
VEGF RI MAB321 Mouse NRS 10%
MP 5% 10 R&D
VEGF RII AF357 Goat NDS 10% 0.5 R&D
CD105 AF1097 Goat NDS 10% 0.5 R&D
Secondary
Rabbit-biotin 711-065-152 Donkey 1:500 ST
Goat-biotin 705-065-147 Donkey 1:500 ST
Mouse-biotin E0354 Rabbit 1:200 D
Goat-FITC 705-095-147 Donkey 1:50 ST
SA: 016-010-084 1:250 ST
SA-Texas red SA-5006 1:100 V
CS, Cell Signaling Technology Inc. (Danvers, MA); D, DAKO (Glostrup, Denmark); FITC, fluorescein isothiocyanate; NDS, normal donkey serum; NRS,
normal rabbit serum; MP, non-fat milk powder; R&D (Abingdon, UK); SA, streptavidin; SC, Santa Cruz Biotechnology (Santa Cruz, CA); SE, Serotec
(Kidlington, UK); ST, Stratech (Cambridge, UK); TGF, transforming growth factor; V, Vector (Peterborough, UK); VEGF, vascular endothelial growth factor.
GP is a kind gift from Dr Gordon Paul, Institute of Leather, Nottingham, UK.
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stability (Danielsen, 1990). Approximately 5 mg of pulverized tissue
was incubated with 250ml 0.4 mg/ml pepsin in 0.5 M acetic acid for
60 hours at 301C. The digest was separated from the residual pellet
by centrifugation at 13,000 g, and both the supernatant and pellet
were analyzed for collagen content as described above. Suscept-
ibility to pepsin digestion was expressed as the percentage of the
total hydroxyproline released into solution.
Mechanical strength
Longitudinal skin samples (25 10 mm) were taken without tension
and excess fat was excised. The skin was dried between layers of
filter paper in order to remove excess tissue fluid, and was fashioned
into a dumbbell shape using a punch biopsy tool, giving a standard
central width of 2.5 mm.
The cornified layer was then gently removed with emery paper
over the sample ends in order to prevent sloughing stratum cornea
causing slippage in the clamps. Emery paper was cut into
15 30 mm rectangles, scored and folded to give double-sided
squares with the abrasive surface facing inward. Loctite 406
cyanoacrylate adhesive (Loctite, Welwyn Garden City, Herts, UK)
was added to one of these surfaces and the distal 10 mm of our skin
sample placed epithelial surface down onto this. A longitudinal
incision was then made centrally through the end 5 mm of the
adhered sample on the exposed side in order to divide any
hypodermis present and the sample was spatulated. Adhesive was
applied to the upper surface and the emery paper folded over and
held for 1 minute. The process was then repeated for the other end of
the sample, leaving a 5 mm hourglass-shaped skin section between
squares of emery paper. Specimens were loaded onto an Instron
6033 materials testing apparatus (Instron, High Wycombe, UK) using
100 N static load cell and gripped with pneumatic clamps set to
120 N/m2. Slack taken up by loading the skin to 0.5 N. The thickness
and width of the sample were then measured using vernier calipers.
Skin samples were loaded to failure at a strain rate of 1 cm/min
and data recorded using a PC equipped with series IX data
acquisition and analysis software (Instron). A load-deformation
curve was constructed from which the maximum load (Fmax) at
failure was obtained. Breaking stress was then calculated as Fmax (N)/
original cross-sectional area (mm2), and expressed as MPa.
Statistical analyses
All data are expressed as the mean7SEM. Two-tailed Wilcoxon-
matched pairs signed ranks tests were performed on paired data,
with unpaired t-tests on controls, using Instat& software. Probabilities
are given as P-values, with Po0.05 regarded as significant.
Normality of the data was assessed using Instat software and
corrected where necessary with a Welch correction.
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